Global Kidney Cancer Drug Market Research Report 2016

September 2016 | 126 pages | ID: G5B30E3ED05EN
QYResearch

Abstracts

Notes:

Production, means the output of Kidney Cancer Drug

Revenue, means the sales value of Kidney Cancer Drug

This report studies Kidney Cancer Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Bayer
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Abbott Laboratories
• Active Biotech
• Amgen
• Argos Therapeutics
• ArQule
• AVEO Pharmaceuticals
• Bionomics
• Bristol-Myers Squibb
• Cerulean Pharma
• Exelixis
• Genentech
• immatics biotechnologies
• Immunicum
• Ono Pharmaceutical
• Onyx Therapeutics
• Oxford BioMedica
• Prometheus Laboratories
• Seattle Genetics
• Taiwan Liposome
• TRACON Pharmaceuticals
• Wilex

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Kidney Cancer Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Kidney Cancer Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Kidney Cancer Drug Market Research Report 2016

1 KIDNEY CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Kidney Cancer Drug Segment by Type
  1.2.1 Global Production Market Share of Kidney Cancer Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Kidney Cancer Drug Segment by Application
  1.3.1 Kidney Cancer Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Kidney Cancer Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Kidney Cancer Drug (2011-2021)

2 GLOBAL KIDNEY CANCER DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Kidney Cancer Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Kidney Cancer Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Kidney Cancer Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Kidney Cancer Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Kidney Cancer Drug Market Competitive Situation and Trends
  2.5.1 Kidney Cancer Drug Market Concentration Rate
  2.5.2 Kidney Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL KIDNEY CANCER DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Kidney Cancer Drug Production and Market Share by Region (2011-2016)
3.2 Global Kidney Cancer Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL KIDNEY CANCER DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Kidney Cancer Drug Consumption by Regions (2011-2016)
4.2 North America Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Kidney Cancer Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL KIDNEY CANCER DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Kidney Cancer Drug Production and Market Share by Type (2011-2016)
5.2 Global Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Kidney Cancer Drug Price by Type (2011-2016)
5.4 Global Kidney Cancer Drug Production Growth by Type (2011-2016)

6 GLOBAL KIDNEY CANCER DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Kidney Cancer Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Kidney Cancer Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL KIDNEY CANCER DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Bayer
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Kidney Cancer Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bayer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 F. Hoffmann-La Roche
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Kidney Cancer Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 F. Hoffmann-La Roche Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Kidney Cancer Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 GlaxoSmithKline Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Kidney Cancer Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Novartis Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Kidney Cancer Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Abbott Laboratories
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Kidney Cancer Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Abbott Laboratories Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Active Biotech
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Kidney Cancer Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Active Biotech Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Amgen
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Kidney Cancer Drug Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Amgen Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Argos Therapeutics
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Kidney Cancer Drug Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Argos Therapeutics Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 ArQule
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Kidney Cancer Drug Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 ArQule Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 AVEO Pharmaceuticals
7.12 Bionomics
7.13 Bristol-Myers Squibb
7.14 Cerulean Pharma
7.15 Exelixis
7.16 Genentech
7.17 immatics biotechnologies
7.18 Immunicum
7.19 Ono Pharmaceutical
7.20 Onyx Therapeutics
7.21 Oxford BioMedica
7.22 Prometheus Laboratories
7.23 Seattle Genetics
7.24 Taiwan Liposome
7.25 TRACON Pharmaceuticals
7.26 Wilex

8 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

8.1 Kidney Cancer Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Kidney Cancer Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Kidney Cancer Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL KIDNEY CANCER DRUG MARKET FORECAST (2016-2021)

12.1 Global Kidney Cancer Drug Production, Revenue Forecast (2016-2021)
12.2 Global Kidney Cancer Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Kidney Cancer Drug Production Forecast by Type (2016-2021)
12.4 Global Kidney Cancer Drug Consumption Forecast by Application (2016-2021)
12.5 Kidney Cancer Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Figure Global Production Market Share of Kidney Cancer Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Kidney Cancer Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Kidney Cancer Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Kidney Cancer Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Kidney Cancer Drug Production of Key Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Production Share by Manufacturers
Figure 2016 Kidney Cancer Drug Production Share by Manufacturers
Table Global Kidney Cancer Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table Global Market Kidney Cancer Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Kidney Cancer Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Kidney Cancer Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Kidney Cancer Drug Product Type
Figure Kidney Cancer Drug Market Share of Top 3 Manufacturers
Figure Kidney Cancer Drug Market Share of Top 5 Manufacturers
Table Global Kidney Cancer Drug Production by Regions (2011-2016)
Figure Global Kidney Cancer Drug Production and Market Share by Regions (2011-2016)
Figure Global Kidney Cancer Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Kidney Cancer Drug Production Market Share by Regions
Table Global Kidney Cancer Drug Revenue by Regions (2011-2016)
Table Global Kidney Cancer Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Kidney Cancer Drug Revenue Market Share by Regions
Table Global Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Kidney Cancer Drug Consumption Market by Regions (2011-2016)
Table Global Kidney Cancer Drug Consumption Market Share by Regions (2011-2016)
Figure Global Kidney Cancer Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Kidney Cancer Drug Consumption Market Share by Regions
Table North America Kidney Cancer Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Kidney Cancer Drug Production, Consumption, Import & Export (2011-2016)
Table China Kidney Cancer Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Kidney Cancer Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Kidney Cancer Drug Production, Consumption, Import & Export (2011-2016)
Table India Kidney Cancer Drug Production, Consumption, Import & Export (2011-2016)
Table Global Kidney Cancer Drug Production by Type (2011-2016)
Table Global Kidney Cancer Drug Production Share by Type (2011-2016)
Figure Production Market Share of Kidney Cancer Drug by Type (2011-2016)
Figure 2015 Production Market Share of Kidney Cancer Drug by Type
Table Global Kidney Cancer Drug Revenue by Type (2011-2016)
Table Global Kidney Cancer Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Kidney Cancer Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Kidney Cancer Drug by Type
Table Global Kidney Cancer Drug Price by Type (2011-2016)
Figure Global Kidney Cancer Drug Production Growth by Type (2011-2016)
Table Global Kidney Cancer Drug Consumption by Application (2011-2016)
Table Global Kidney Cancer Drug Consumption Market Share by Application (2011-2016)
Figure Global Kidney Cancer Drug Consumption Market Share by Application in 2015
Table Global Kidney Cancer Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Kidney Cancer Drug Consumption Growth Rate by Application (2011-2016)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Kidney Cancer Drug Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Kidney Cancer Drug Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Kidney Cancer Drug Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Kidney Cancer Drug Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Kidney Cancer Drug Market Share (2011-2016)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Kidney Cancer Drug Market Share (2011-2016)
Table Active Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Active Biotech Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Active Biotech Kidney Cancer Drug Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Kidney Cancer Drug Market Share (2011-2016)
Table Argos Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Argos Therapeutics Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Argos Therapeutics Kidney Cancer Drug Market Share (2011-2016)
Table ArQule Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ArQule Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure ArQule Kidney Cancer Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Global Kidney Cancer Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Kidney Cancer Drug Production Forecast by Regions (2016-2021)
Table Global Kidney Cancer Drug Consumption Forecast by Regions (2016-2021)
Table Global Kidney Cancer Drug Production Forecast by Type (2016-2021)
Table Global Kidney Cancer Drug Consumption Forecast by Application (2016-2021)